ARKG Holdings of Exact Sciences Corp. (EXAS) - Updated Daily

Join Premium Plan

Shares HeldWeight In Fund

Trades of EXAS Made In ARKG

Why do the number of shares of a company held in an ARK ETF go up or down even when no trades are reported?

The Bucket ReportSubscribe to get all the important numbers from the financial markets delivered to your inbox every trading day 📫

Date	Direction	Shares	Fund Weight	Fund

January 21, 2022	BUY	181.365k	0.3493%	ARKG
January 20, 2022	BUY	172.207k	0.3432%	ARKG
January 12, 2022	BUY	41.103k	0.0724%	ARKG
January 11, 2022	BUY	300.000	0.0005%	ARKG
January 10, 2022	BUY	49.498k	0.0785%	ARKG

Statistics

Clinical Trials (20)

Institutional Ownership Trends

News That Matters

Description
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Website
www.exactsciences.com